However, it is common in oncology laboratory tests to identify biomarkers in breast tumor samples using histological techniques, such as immunohistochemistry, for the detection of detect biomarkers such as Ki67 [50] and estrogen receptor [6] and in situ hybridization for the detection of HER2 amplification [51]. Here, ERBB2 is linked to breast neoplasm.